Cargando…

Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System

Purpose. To evaluate the contribution of the ocular risk factors in the conversion of the fellow eye of patients with unilateral exudative AMD, using a novel semiautomated grading system. Materials and Methods. Single-center, retrospective study including 89 consecutive patients with unilateral exud...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, João Pedro, Costa, Miguel, Melo, Pedro, Oliveira, Carlos Manta, Pires, Isabel, Cachulo, Maria Luz, Figueira, João, Silva, Rufino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910538/
https://www.ncbi.nlm.nih.gov/pubmed/24555130
http://dx.doi.org/10.1155/2013/464218
_version_ 1782301984064274432
author Marques, João Pedro
Costa, Miguel
Melo, Pedro
Oliveira, Carlos Manta
Pires, Isabel
Cachulo, Maria Luz
Figueira, João
Silva, Rufino
author_facet Marques, João Pedro
Costa, Miguel
Melo, Pedro
Oliveira, Carlos Manta
Pires, Isabel
Cachulo, Maria Luz
Figueira, João
Silva, Rufino
author_sort Marques, João Pedro
collection PubMed
description Purpose. To evaluate the contribution of the ocular risk factors in the conversion of the fellow eye of patients with unilateral exudative AMD, using a novel semiautomated grading system. Materials and Methods. Single-center, retrospective study including 89 consecutive patients with unilateral exudative AMD and ≥3 years of followup. Baseline color fundus photographs were graded using an innovative grading software, RetmarkerAMD (Critical Health SA). Results. The follow-up period was 60.9 ± 31.3 months. The occurrence of CNV was confirmed in 42 eyes (47.2%). The cumulative incidence of CNV was 23.6% at 2 years, 33.7% at 3 years, 39.3% at 5 years, and 47.2% at 10 years, with a mean annual incidence of 12.0% (95% CI = 0.088–0.162). The absolute number of drusen in the central 1000 and 3000 μm (P < 0.05) and the absolute number of drusen ≥125 µm in the central 3000 and 6000 µm (P < 0.05) proved to be significant risk factors for CNV. Conclusion. The use of quantitative variables in the determination of the OR of developing CNV allowed the establishment of significant risk factors for neovascularization. The long follow-up period and the innovative methodology reinforce the value of our results. This trial is registered with ClinicalTrials.gov NCT00801541.
format Online
Article
Text
id pubmed-3910538
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39105382014-02-19 Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System Marques, João Pedro Costa, Miguel Melo, Pedro Oliveira, Carlos Manta Pires, Isabel Cachulo, Maria Luz Figueira, João Silva, Rufino ISRN Ophthalmol Clinical Study Purpose. To evaluate the contribution of the ocular risk factors in the conversion of the fellow eye of patients with unilateral exudative AMD, using a novel semiautomated grading system. Materials and Methods. Single-center, retrospective study including 89 consecutive patients with unilateral exudative AMD and ≥3 years of followup. Baseline color fundus photographs were graded using an innovative grading software, RetmarkerAMD (Critical Health SA). Results. The follow-up period was 60.9 ± 31.3 months. The occurrence of CNV was confirmed in 42 eyes (47.2%). The cumulative incidence of CNV was 23.6% at 2 years, 33.7% at 3 years, 39.3% at 5 years, and 47.2% at 10 years, with a mean annual incidence of 12.0% (95% CI = 0.088–0.162). The absolute number of drusen in the central 1000 and 3000 μm (P < 0.05) and the absolute number of drusen ≥125 µm in the central 3000 and 6000 µm (P < 0.05) proved to be significant risk factors for CNV. Conclusion. The use of quantitative variables in the determination of the OR of developing CNV allowed the establishment of significant risk factors for neovascularization. The long follow-up period and the innovative methodology reinforce the value of our results. This trial is registered with ClinicalTrials.gov NCT00801541. Hindawi Publishing Corporation 2013-07-30 /pmc/articles/PMC3910538/ /pubmed/24555130 http://dx.doi.org/10.1155/2013/464218 Text en Copyright © 2013 João Pedro Marques et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Marques, João Pedro
Costa, Miguel
Melo, Pedro
Oliveira, Carlos Manta
Pires, Isabel
Cachulo, Maria Luz
Figueira, João
Silva, Rufino
Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
title Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
title_full Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
title_fullStr Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
title_full_unstemmed Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
title_short Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
title_sort ocular risk factors for exudative amd: a novel semiautomated grading system
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910538/
https://www.ncbi.nlm.nih.gov/pubmed/24555130
http://dx.doi.org/10.1155/2013/464218
work_keys_str_mv AT marquesjoaopedro ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem
AT costamiguel ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem
AT melopedro ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem
AT oliveiracarlosmanta ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem
AT piresisabel ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem
AT cachulomarialuz ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem
AT figueirajoao ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem
AT silvarufino ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem